Fu Peng

1.9k total citations
55 papers, 1.4k citations indexed

About

Fu Peng is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Fu Peng has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Pharmacology. Recurrent topics in Fu Peng's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Natural product bioactivities and synthesis (5 papers). Fu Peng is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and Natural product bioactivities and synthesis (5 papers). Fu Peng collaborates with scholars based in China, Macao and United Kingdom. Fu Peng's co-authors include Cheng Peng, Lei Yu, Jun Xie, Xiaofang Xie, Hailin Tang, Jianping Chen, Qingqing Liu, Junren Chen, Gangmin Li and Yan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Plant Journal and International Journal of Molecular Sciences.

In The Last Decade

Fu Peng

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu Peng China 22 772 320 197 169 158 55 1.4k
Meran Keshawa Ediriweera Sri Lanka 20 832 1.1× 345 1.1× 183 0.9× 104 0.6× 117 0.7× 57 1.6k
Jaemoo Chun South Korea 22 1.1k 1.4× 454 1.4× 187 0.9× 153 0.9× 191 1.2× 48 1.8k
Yanru Li China 27 1.2k 1.5× 374 1.2× 269 1.4× 95 0.6× 74 0.5× 78 1.8k
Maolun Liu China 13 710 0.9× 250 0.8× 90 0.5× 131 0.8× 100 0.6× 16 1.3k
Subapriya Rajamanickam United States 17 805 1.0× 312 1.0× 113 0.6× 202 1.2× 90 0.6× 24 1.3k
Mun-Ock Kim South Korea 23 956 1.2× 194 0.6× 210 1.1× 97 0.6× 119 0.8× 59 1.7k
Xinmei Kang China 19 661 0.9× 228 0.7× 232 1.2× 77 0.5× 113 0.7× 29 1.5k
Jiaqing Cao China 24 852 1.1× 215 0.7× 334 1.7× 67 0.4× 174 1.1× 122 1.6k

Countries citing papers authored by Fu Peng

Since Specialization
Citations

This map shows the geographic impact of Fu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Peng more than expected).

Fields of papers citing papers by Fu Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Peng. The network helps show where Fu Peng may publish in the future.

Co-authorship network of co-authors of Fu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Fu Peng. A scholar is included among the top collaborators of Fu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu Peng. Fu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pu, Shi, et al.. (2025). Sodium's role and therapeutic targeting in cancer. Trends in Pharmacological Sciences. 47(1). 53–65.
3.
Zhang, Limei, Shan Liao, Jihai Gao, et al.. (2025). A comprehensive review of ethnopharmacology, phytochemistry, pharmacological effects, and quality control of Bletilla striata. Journal of Ethnopharmacology. 353(Pt A). 120273–120273.
4.
Zhang, Heng, Hailin Tang, Wenling Tu, & Fu Peng. (2025). Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers. Cancer Drug Resistance. 8. 4–4. 3 indexed citations
5.
Wang, Fang, Zhaokai Zhou, Run Shi, et al.. (2025). CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies. Frontiers in Endocrinology. 16. 1517525–1517525. 1 indexed citations
6.
Zhang, Yuan, Chenghao Yu, Cheng Peng, & Fu Peng. (2024). Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis. International Journal of Biological Sciences. 20(12). 4838–4852. 13 indexed citations
7.
Xiong, Fang, et al.. (2024). Investigation of polysaccharide from Radix Aconiti Lateralis Preparata (Fuzi) cardio protective effect on doxorubicin-induced chronic cardiotoxicity. Journal of Pharmacy and Pharmacology. 76(4). 391–404. 6 indexed citations
8.
Zhou, Zhaokai, Ge Zhang, Shuai Yang, et al.. (2024). The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?. Cancer Letters. 597. 217083–217083. 12 indexed citations
9.
Yu, Qian, Luyao Sun, Fu Peng, et al.. (2023). Antimicrobial Activity of Stilbenes from Bletilla striata against Cutibacterium acnes and Its Effect on Cell Membrane. Microorganisms. 11(12). 2958–2958. 3 indexed citations
10.
Liu, Aiqun, et al.. (2023). Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway. SHILAP Revista de lepidopterología. 4(3). e282–e282. 46 indexed citations
11.
Chen, Yan, Fu Peng, Song Gao, et al.. (2023). The mechanism of action of safflower total flavonoids in the treatment of endometritis caused by incomplete abortion based on network pharmacology and 16S rDNA sequencing. Journal of Ethnopharmacology. 315. 116639–116639. 7 indexed citations
12.
Li, Xin, et al.. (2023). New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis. Biomedicine & Pharmacotherapy. 163. 114806–114806. 16 indexed citations
13.
Chen, Junren, Lin Pu, Lei Yu, et al.. (2023). Galangin: A food‐derived flavonoid with therapeutic potential against a wide spectrum of diseases. Phytotherapy Research. 37(12). 5700–5723. 37 indexed citations
14.
Peng, Fu, Li Wang, Liang Xiong, et al.. (2022). Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression. Frontiers in Pharmacology. 13. 806869–806869. 28 indexed citations
15.
Li, Qiuju, Fu Peng, Xiaoyu Yan, et al.. (2022). Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro. Journal of Ethnopharmacology. 303. 116029–116029. 48 indexed citations
16.
Chen, Wei, et al.. (2021). Developmental Stages of Akebia trifoliata Fruit Based on Volume. Horticultural Science and Technology. 39(6). 823–831. 19 indexed citations
17.
Li, Gangmin, Junren Chen, Huiqiong Zhang, et al.. (2021). Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 47 indexed citations
18.
Peng, Fu, Xianmei Yin, Junren Chen, et al.. (2021). The chromosome-scale genome of Magnolia officinalis provides insight into the evolutionary position of magnoliids. iScience. 24(9). 102997–102997. 21 indexed citations
19.
Chen, Guan‐Ru, Xiaofang Xie, Fu Peng, et al.. (2021). Protective effect of the combination of essential oil from patchouli and tangerine peel against gastric ulcer in rats. Journal of Ethnopharmacology. 282. 114645–114645. 17 indexed citations
20.
Yang, Anli, Fu Peng, Xing Li, et al.. (2021). Melatonin inhibits triple-negative breast cancer progression through the Lnc049808-FUNDC1 pathway. Cell Death and Disease. 12(8). 712–712. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026